AffaMed Therapeutics Announces First Patient Dosed in the US Phase 1 Clinical Trial of AM712 in Retinal Disease

/PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative...

Related Keywords

China ,Japan ,United States ,Shanghai ,Dayao Zhao ,Askgene Pharma Inc ,Drug Administration ,Affamed Therapeutics ,Askgene Pharma ,Investigational New Drug ,United States Food ,Amed Therapeutics ,Greater China ,